Prostate Cancer Support Group

USPSTF Recommendation Could Benefit PCA3 Test

DiagnoCure’s PCA3 test received FDA approval in February 2012 to assess the risk of prostate cancer in men following a prior negative biopsy.  The FDA-approved test, Progensa PCA3, is marketed by Gen-Probe (GPRO) and could offer a better alternative to PSA testing.

An over-the-counter natural remedy derived from honeybee hives arrests the growth of prostate cancer cells and tumors in mice, according to a new paper from researchers at the University of Chicago Medicine. Caffeic acid phenethyl ester, or CAPE, is a compound isolated from honeybee hive propolis, the resin used by bees to patch up holes in hives.

Advanced Prostate
Cancer Fact Sheet

(From Urologyhealth.org)

Of the 200,000 men who will be diagnosed with prostate cancer this year 5-10% will involve advanced
disease. While doctors prefer to find the disease in its earliest and most treatable stages. But
for men diagnosed with advanced prostate cancer, the prognosis is getting better all the time.
There are a number of effective treatments avail- able. However, before deciding on any treatment
options it is impor- tant to understand advanced prostate cancer is a very complex dis- ease. It is
critical patients and physicians come together to map out a treatment solution that works well for
a man’s over health and life- style.